Clinical Trials Directory

Trials / Terminated

TerminatedNCT02059356

Ammonia Levels and Cognitive Impairment

Prevalence of High Ammonia Levels in Patients With Cognitive Impairment. Does Treatment Help?

Status
Terminated
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose and objective of this study is to determine the prevalence of elevated ammonia levels in subjects with cognitive impairment, and to observe if treating the cause of the elevated ammonia level improves mental status. This study does not include any imaging, treatment,or interventions, other than the blood draws. The blood draws will be taken to assess blood ammonia level and liver function. If the the ammonia level is not elevated, no further lab draws will occur. If the ammonia level is elevated, liver function is normal, and a cause for the high ammonia level is revealed with a plan for clinical treatment by the subjects' physician, then two more blood draws will occur; one prior to treatment, and one 3 months after treatment. The main risk to subjects is related to the blood draw (i.e. momentary discomfort, bruising, infection, bleeding, clotting or fainting), and there is a potential loss of confidentiality. A paired student t test will be done with the two later blood to compare objective data.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2015-03-01
First posted
2014-02-11
Last updated
2015-03-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02059356. Inclusion in this directory is not an endorsement.